ストックスクリーナーアプリを入手
12.11
1.54%
-0.19
前日終値:
$12.30
開ける：
$12.15
24時間の取引高:
402.27K
Relative Volume:
0.85
時価総額：
$492.08M
収益：
$324.01M
当期純損益:
$-192.37M
株価収益率:
-2.5335
EPS:
-4.78
ネットキャッシュフロー:
$-23.46M
1週間 パフォーマンス:
+0.75%
1か月 パフォーマンス:
+6.13%
6か月 パフォーマンス:
+30.36%
1年 パフォーマンス:
+76.79%
1日の値動き範囲:
$12.02
$12.30
1週間の範囲:
$12.02
$12.84
52週間の値動き範囲:
$6.63
$13.50
Angiodynamic Inc Stock (ANGO) Company Profile
ANGO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
12.11 | 506.76M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-16 | 開始されました | Lake Street | Buy |
| 2024-04-05 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-09-25 | 開始されました | H.C. Wainwright | Buy |
| 2023-04-17 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | 開始されました | Oppenheimer | Perform |
| 2020-11-25 | アップグレード | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | ダウングレード | Craig Hallum | Buy → Hold |
| 2017-04-07 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-03-30 | ダウングレード | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | 開始されました | Barclays | Equal Weight |
| 2016-11-04 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-04-08 | 再開されました | Piper Jaffray | Neutral |
| 2016-01-08 | 繰り返されました | Canaccord Genuity | Buy |
| 2015-11-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | 繰り返されました | Canaccord Genuity | Hold |
| 2012-06-25 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | アップグレード | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | ダウングレード | Wedbush | Neutral → Underperform |
| 2010-09-08 | 繰り返されました | Wedbush | Neutral |
すべてを表示
Angiodynamic Inc (ANGO) 最新ニュース
How strong is AngioDynamics Inc. stock balance sheetTake Profit & Low Risk High Reward Ideas - Fundação Cultural do Pará
Why AngioDynamics Inc. stock is in analyst buy zoneJuly 2025 Reactions & Weekly High Conviction Trade Ideas - Fundação Cultural do Pará
How AngioDynamics Inc. stock reacts to job market dataTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
AngioDynamics, Inc. $ANGO Stock Position Raised by Pier Capital LLC - MarketBeat
AngioDynamics Raises Forecast As Med Tech Sales Outperform - Finimize
Why analysts upgrade AngioDynamics Inc. stockJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Fundação Cultural do Pará
Why analysts raise outlook for AngioDynamics Inc. (UG2) stockTrade Performance Summary & AI Driven Price Forecasts - Fundação Cultural do Pará
AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan
H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance - Yahoo Finance
Insider Buying: Lawrence Weiss Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus
ANGO registers 4.7M plan shares and covers 2.53M insider resales - Stock Titan
What hedge fund activity signals for AngioDynamics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com
Will AngioDynamics Inc. stock continue dividend increasesWeekly Trade Summary & Consistent Income Trade Recommendations - Trung tâm Dự báo KTTV quốc gia
Insider Spends US$112k Buying More Shares In AngioDynamics - Yahoo Finance
Is AngioDynamics Inc. stock a good choice for value investors2025 Valuation Update & Precise Trade Entry Recommendations - Trung tâm Dự báo KTTV quốc gia
Ideas Watch: Will AngioDynamics Inc. stock return to pre crisis levels2025 Risk Factors & Low Drawdown Trading Strategies - Trung tâm Dự báo KTTV quốc gia
Why AngioDynamics Inc. (UG2) stock trades below fair valueJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Day Trade: Is AngioDynamics Inc. stock a good choice for value investorsPortfolio Risk Summary & Long-Term Growth Portfolio Plans - Trung tâm Dự báo KTTV quốc gia
AngioDynamics, Inc. (ANGO) Stock Analysis: A 57.85% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Time magazine names Latham-based AngioDynamics' cancer-fighting NanoKnife a top invention - Times Union
Published on: 2025-10-15 06:33:40 - newser.com
Analyzing AngioDynamics Inc. with multi timeframe chartsJuly 2025 Decliners & Smart Investment Allocation Insights - newser.com
Insider Buying: Stephen Trowbridge Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus
Can technical indicators confirm AngioDynamics Inc.’s reversal - newser.com
Custom watchlist performance reports with AngioDynamics Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List - Stock Titan
AngioDynamics CEO, President & Director Acquires 1.9% More Stock - simplywall.st
AngioDynamics Inc (ANGO) CEO James Clemmer Purchases 10,000 Shar - GuruFocus
AngioDynamics Inc UG2 Stock Analysis and ForecastBreakout Stock Watch & Capital Efficiency Improvement - earlytimes.in
AngioDynamics Eyes Growth Despite Tariffs - Yahoo Finance
AngioDynamics (NASDAQ:ANGO) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
ANGIODYNAMICS INC SEC 10-Q Report - TradingView
AngioDynamics Inc (ANGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo Finance
AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha
Why Did AngioDynamics Stock Pop Today? - The Motley Fool
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results - Benzinga
AngioDynamics Inc reports results for the quarter ended August 31Earnings Summary - TradingView
Transcript : AngioDynamics, Inc., Q1 2026 Earnings Call, Oct 02, 2025 - MarketScreener
AngioDynamics, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 - MarketScreener
AngioDynamics Inc. Q1 Loss Decreases, Beats Estimates - Nasdaq
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In FocusSPDR S&P 500 (ARCA:SPY) - Benzinga
Voya Investment Management LLC Has $103,000 Position in AngioDynamics, Inc. $ANGO - Defense World
AngioDynamics (ANGO) Updates FY26 Revenue and EPS Projections - GuruFocus
Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings - Benzinga
Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result - Yahoo Finance
AngioDynamics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
What drives AngioDynamics Inc stock pricePrice Volatility Patterns & Master Technical Analysis With Free Tools - earlytimes.in
Chart based analysis of AngioDynamics Inc. trendsJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com
Why AngioDynamics Inc. (UG2) stock signals breakout potentialJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Is AngioDynamics Inc. (UG2) stock a safe buy pre earningsMarket Performance Summary & AI Powered Market Entry Ideas - newser.com
How buyback programs support AngioDynamics Inc. (UG2) stock2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Angiodynamic Inc (ANGO) 財務データ
収益
当期純利益
現金流量
EPS
1.23%
0.58%
大文字化:
|
ボリューム (24 時間):